Intracranial dural arteriovenous fistulas (DAVF) are pathological connections between dural arteries and dural venous sinuses, cortical veins, or meningeal veins. DAVFs constitute 10 to 15% of all intracranial vascular malformations. They are most commonly acquired lesions of unknown etiology, whose occurrence is associated with intracranial venous sinus thrombosis leading to the development of venous hypertension. They are classified using the Cognard and Borden classifications, which take into account the localization of lesions and venous drainage, angioarchitecture, presence/absence of cortical venous drainage, and direction of blood flow. The type of the lesion is determined using available classifications, which helps decide which therapeutic option to use. The clinical presentation varies depending on the location of the lesions and the type of venous drainage, ranging from asymptomatic lesions to potentially fatal lesions due to rupture and cerebral hemorrhage. Digital subtraction angiography is the gold standard for diagnosing DAVFs. Therapeutic options include conservative treatment, radiation therapy, endovascular interventions, and surgical treatment, with the decision based on factors such as the type and location of the lesion, and the patient's personal history and current condition. The first-line treatment for fistulas is endovascular intervention, either transarterial or transvenous, aiming for complete fistula closure to cure the symptoms and prevent potential complications.